Unification of regulatory approval

This page is under construction and edited by Susan Liu EMBA09. In case of any questions/remarks, feel free to contact me

Description:

A short description of the driving force.

Seeing the benefit and the effectiveness of the European Union, countries in different regions start forming alliances and use common rules for regulations and policies. This can mean a unified regulations and approval process for pharmeceutical regulations.

In addition, the WHO is working closely with the WTO to put pressure on Afican countries and the IMF to ensure drugs can be delivered to the ones who need them. If they do not do so, aids and funds would be limited or even denied.

Enablers:

Political Alliances

Regional Development

WHO initiatives to distribute drugs worldwide for those in need

Inhibitors:

Political Chaos

De-globolization

Paradigms:

Changes in ways of thinking about the world due to the driving force.

Experts:

Martin D. Hynes--Pharmaceutical Pre-Approval Inspections: A Guide to Regulatory

The Generic Pharmaceutical Industry Association (GPIA)

National Pharmaceutical Alliance (NPA)

WHO

Timing:

Dates for key milestones in the development of the driving force.

Web Resources:

Useful resources on the web relating to this force.